ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 87 filers reported holding ADURO BIOTECH INC in Q4 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $513,000 | +51.8% | 128,965 | +0.8% | 0.00% | – |
Q4 2018 | $338,000 | -89.5% | 127,929 | -70.9% | 0.00% | -100.0% |
Q3 2018 | $3,230,000 | +35.9% | 439,356 | +29.4% | 0.00% | -50.0% |
Q2 2018 | $2,376,000 | +51.7% | 339,409 | +101.5% | 0.00% | +100.0% |
Q1 2018 | $1,566,000 | +65.0% | 168,416 | +33.1% | 0.00% | 0.0% |
Q4 2017 | $949,000 | -17.0% | 126,577 | +17.9% | 0.00% | 0.0% |
Q3 2017 | $1,143,000 | -5.5% | 107,341 | +1.1% | 0.00% | 0.0% |
Q2 2017 | $1,210,000 | +14.4% | 106,153 | +7.8% | 0.00% | 0.0% |
Q1 2017 | $1,058,000 | -9.2% | 98,443 | -3.7% | 0.00% | 0.0% |
Q4 2016 | $1,165,000 | -36.3% | 102,203 | -30.6% | 0.00% | 0.0% |
Q3 2016 | $1,830,000 | +28.8% | 147,227 | +17.1% | 0.00% | 0.0% |
Q2 2016 | $1,421,000 | +302.5% | 125,683 | +355.9% | 0.00% | – |
Q1 2016 | $353,000 | -75.4% | 27,570 | -46.0% | 0.00% | -100.0% |
Q4 2015 | $1,437,000 | +169.1% | 51,060 | +85.2% | 0.00% | – |
Q3 2015 | $534,000 | +58.0% | 27,570 | +147.1% | 0.00% | – |
Q2 2015 | $338,000 | – | 11,158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |